These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33363095)

  • 1. Factors Related to Non-participation in the Basque Country Colorectal Cancer Screening Programme.
    Solís-Ibinagagoitia M; Unanue-Arza S; Díaz-Seoane M; Martínez-Indart L; Lebeña-Maluf A; Idigoras I; Bilbao I; Portillo I
    Front Public Health; 2020; 8():604385. PubMed ID: 33363095
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.
    Guiriguet C; Pera G; Castells A; Toran P; Grau J; Rivero I; Buron A; Macià F; Vela-Vallespín C; Vilarrubí-Estrella M; Marzo-Castillejo M
    BMC Cancer; 2017 Aug; 17(1):524. PubMed ID: 28784093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care.
    Guiriguet C; Muñoz-Ortiz L; Burón A; Rivero I; Grau J; Vela-Vallespín C; Vilarrubí M; Torres M; Hernández C; Méndez-Boo L; Toràn P; Caballeria L; Macià F; Castells A
    Br J Gen Pract; 2016 Jul; 66(648):e483-90. PubMed ID: 27266861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors related to the participation and detection of lesions in colorectal cancer screening programme-based faecal immunochemical test.
    Portillo I; Arana-Arri E; Gutiérrez-Ibarluzea I; Bilbao I; Luis Hurtado J; Sarasqueta C; Idigoras I; Bujanda L;
    Eur J Public Health; 2018 Dec; 28(6):1143-1148. PubMed ID: 29982586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Main results of the colorectal cancer screening program in the Basque Country (Spain)].
    Portillo I; Idígoras I; Ojembarrena E; Arana-Arri E; Zubero MB; Pijoán JI; López Urrutia A; Marqués ML
    Gac Sanit; 2013; 27(4):358-61. PubMed ID: 23416028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme.
    van de Schootbrugge-Vandermeer HJ; Lansdorp-Vogelaar I; de Jonge L; van Vuuren AJ; Dekker E; Spaander MCW; Ramakers CRB; Nagtegaal ID; van Kemenade FJ; van Leerdam ME; Toes-Zoutendijk E
    Eur J Cancer; 2023 Sep; 190():112942. PubMed ID: 37406529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lesions detected in a colorectal cancer screening program in the Basque Country: first round (2009-2011)].
    Portillo I; Idígoras I; Ojembarrena E; Arana E; Luis Hurtado J; Basurko R; Tapia M; Luz Peña M
    Gastroenterol Hepatol; 2013 May; 36(5):301-8. PubMed ID: 23618538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model.
    Idigoras I; Arrospide A; Portillo I; Arana-Arri E; Martínez-Indart L; Mar J; de Koning HJ; Lastra R; Soto-Gordoa M; van der Meulen M; Lansdorp-Vogelaar I
    BMC Public Health; 2017 Aug; 18(1):78. PubMed ID: 28764731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social inequalities in a population based colorectal cancer screening programme in the Basque Country.
    Hurtado JL; Bacigalupe A; Calvo M; Esnaola S; Mendizabal N; Portillo I; Idigoras I; Millán E; Arana-Arri E
    BMC Public Health; 2015 Oct; 15():1021. PubMed ID: 26438240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can an alert in primary care electronic medical records increase participation in a population-based screening programme for colorectal cancer? COLO-ALERT, a randomised clinical trial.
    Guiriguet-Capdevila C; Muñoz-Ortiz L; Rivero-Franco I; Vela-Vallespín C; Vilarrubí-Estrella M; Torres-Salinas M; Grau-Cano J; Burón-Pust A; Hernández-Rodríguez C; Fuentes-Peláez A; Reina-Rodríguez D; De León-Gallo R; Mendez-Boo L; Torán-Monserrat P
    BMC Cancer; 2014 Mar; 14():232. PubMed ID: 24685117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Involvement of the Primary Healthcare professionals in the Colorectal Cancer Screening Programme of the Basque Country.].
    Unanue-Arza S; Arana-Arri E; Portillo I; Arostegui I
    Rev Esp Salud Publica; 2021 Jan; 95():. PubMed ID: 33496280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of a brief phone intervention to increase participation in a population-based colorectal cancer screening programme: a randomized controlled trial.
    Selva A; Torà N; Pascual E; Espinàs JA; Baré M
    Colorectal Dis; 2019 Oct; 21(10):1120-1129. PubMed ID: 31099455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe.
    Toes-Zoutendijk E; Portillo I; Hoeck S; de Brabander I; Perrin P; Dubois C; van Leerdam M; Lansdorp-Vogelaar I; Bardou M
    J Med Screen; 2020 Jun; 27(2):68-76. PubMed ID: 31645173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening.
    Clarke N; McNamara D; Kearney PM; O'Morain CA; Shearer N; Sharp L
    Prev Med; 2016 Dec; 93():198-203. PubMed ID: 27765660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Colorectal cancer screening programme in Aragon (Spain): preliminary results].
    Solé Llop ME; Cano Del Pozo M; García Montero JI; Carrera-Lasfuentes P; Lanas Á
    Gac Sanit; 2018; 32(6):559-562. PubMed ID: 28784304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitators and barriers to participation in population-based colorectal cancer screening programme from the perspective of healthcare professionals: Qualitative research study.
    Unanue-Arza S; Portillo I; Idígoras I; Arostegui I; Arana-Arri E
    Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13507. PubMed ID: 34462982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in diagnostic activity in general practice and findings for individuals invited to the danish screening programme for colorectal cancer: a population-based cohort study.
    Juul JS; Andersen B; Laurberg S; Carlsen AH; Olesen F; Vedsted P
    Scand J Prim Health Care; 2018 Sep; 36(3):281-290. PubMed ID: 29929415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Informed participation in the Valencian Community Colorectal Cancer Screening Programme from a gender perspective.
    Molina-Barceló A; Peiró-Pérez R; Vanaclocha M; Vallés G; Guaita L; Salas D
    Gac Sanit; 2018; 32(1):72-76. PubMed ID: 27745772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.